Tierney Saccavino | EVP, Corporate Communications |
Ron Cohen | CEO |
Mike Gesser | CFO |
Ladies and gentlemen, welcome to Acorda Therapeutics' Second Quarter 2022 Financial and Business Update. [Operator Instructions] Please be advised that this call is being recorded at the company's request. I will now introduce your host for today's call, Tierney Saccavino at Acorda. Tierney, please go ahead.
Thank you, Abby, and good afternoon, everyone.